tradingkey.logo

IM Cannabis Corp

IMCC
View Detailed Chart
1.280USD
-0.020-1.54%
Close 02/02, 16:00ETQuotes delayed by 15 min
6.72MMarket Cap
LossP/E TTM

IM Cannabis Corp

1.280
-0.020-1.54%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.54%

5 Days

-6.57%

1 Month

-14.09%

6 Months

-49.41%

Year to Date

-7.91%

1 Year

-41.01%

View Detailed Chart

TradingKey Stock Score of IM Cannabis Corp

Currency: USD Updated: 2026-02-02

Key Insights

IM Cannabis Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 30 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 0.00.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IM Cannabis Corp's Score

Industry at a Glance

Industry Ranking
28 / 30
Overall Ranking
464 / 4529
Industry
Food & Drug Retailing

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

IM Cannabis Corp Highlights

StrengthsRisks
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Growing
The company is in a growing phase, with the latest annual income totaling USD 37.56M.
Undervalued
The company’s latest PE is -1.48, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 964.07K shares, increasing 38.56% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 11.43K shares of this stock.

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

IM Cannabis Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

IM Cannabis Corp Info

IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Ticker SymbolIMCC
CompanyIM Cannabis Corp
CEOFisher (Eyal)
Websitehttps://imcannabis.com/
KeyAI